Exenatide Twice Daily Versus Premixed Insulin Aspart 70/30 in Metformin-Treated Patients With Type 2 Diabetes: A randomized 26-week study on glycemic control and hypoglycemia

OBJECTIVE: Hypoglycemia causes recurrent morbidity in patients with type 2 diabetes. This study evaluated if exenatide twice daily (BID) was noninferior to premixed insulin aspart 70/30 BID (PIA) for glycemic control and associated with less hypoglycemia. RESEARCH DESIGN AND METHODS: In this open-la...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallwitz, Baptist, Böhmer, Michael, Segiet, Thomas, Mölle, Andrea, Milek, Karsten, Becker, Bernd, Helsberg, Karin, Petto, Helmut, Peters, Natalie, Bachmann, Oliver
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041190/
https://www.ncbi.nlm.nih.gov/pubmed/21285388
http://dx.doi.org/10.2337/dc10-1900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041190/
https://www.ncbi.nlm.nih.gov/pubmed/21285388
http://dx.doi.org/10.2337/dc10-1900

Ejemplares similares